Skip to main content
BBNX logo

Beta Bionics, Inc.

BBNXNASDAQHealthcareMedical Devices

$16.39Today:- (-)1Y −13.54%

As of Oct 16, 2026 close

Market cap
$771.08M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.80$32.71
Volume (live)
-
Avg. volume (3M)
1.34M

Beta Bionics, Inc. (BBNX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Beta Bionics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 15 professional research analysts

Consensus Rating

Buy
Based on 15 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$24.57
+49.91% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BBNX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Michael Toomey
Jefferies
BuyInitiates
$30.00
Unknown Analyst
Barclays
BuyInitiates
$30.00
Richard Newitter
Truist
BuyReiterates
$23.00 → $28.00
Larry Biegelsen
Wells Fargo
BuyInitiates
$28.00
Frank Takkinen
Lake Street
BuyReiterates
$25.00
Mike Kratky
Leerink Partners
BuyReiterates
$27.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Jonathan Block
Stifel Nicolaus
BuyMaintains
$20.00 → $22.00
Jonathan Block
Stifel Nicolaus
BuyMaintains
$20.00 → $22.00
Travis Steed
BofA Securities
HoldReiterates
$18.00 → $20.00
Patrick Wood
UBS
BuyMaintains
$22.00 → $25.00
Jeff Johnson
Baird
HoldMaintains
$14.00 → $16.00
Steven Lichtman
William Blair
HoldMaintains
-
Mathew Blackman
TD Cowen
HoldMaintains
$16.00 → $18.00
Travis Steed
BofA Securities
HoldReiterates
$18.00 → $20.00
Jeffrey Cohen
Ladenburg Thalmann
BuyReiterates
$30.40
Matthew O'Brien
Piper Sandler
BuyReiterates
$20.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 12, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BBNX?

The analyst consensus rating for BBNX is Buy, based on the latest ratings from 15 analysts over the last 90 days.

What is the average price target for BBNX?

The average 12-month price target for BBNX is $24.57, representing an upside of 49.9% from the Oct 16, 2026 close of $16.39.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.